AIRVOYA Trademark

Trademark Overview

On Tuesday, June 25, 2019, a trademark application was filed for AIRVOYA with the United States Patent and Trademark Office. The USPTO has given the AIRVOYA trademark a serial number of 88488799. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 29, 2022. This trademark is owned by Intersect ENT Inc.. The AIRVOYA trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery system consisting of a drug-coated balloon dilation device; Medical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate nose anatomy and paranasal sinus ostia for the purpose of delivering pharmaceuticals; medical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate the Eustachian tube to deliver pharmaceuticals for treating ear and auditory-related conditions and symptoms; medical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate pharyngeal and tracheal and esophageal anatomy to deliver pharmaceuticals for treating throat-related conditions and symptoms
airvoya

General Information

Serial Number88488799
Word MarkAIRVOYA
Filing DateTuesday, June 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 29, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesDrug delivery system consisting of a drug-coated balloon dilation device; Medical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate nose anatomy and paranasal sinus ostia for the purpose of delivering pharmaceuticals; medical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate the Eustachian tube to deliver pharmaceuticals for treating ear and auditory-related conditions and symptoms; medical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate pharyngeal and tracheal and esophageal anatomy to deliver pharmaceuticals for treating throat-related conditions and symptoms

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 5, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFIAGON NA LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMENLO PARK, CA 94025
Party NameIntersect ENT Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameIntersect ENT Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, August 29, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 29, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 19, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, January 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 21, 2022SOU EXTENSION 4 GRANTED
Wednesday, January 12, 2022SOU EXTENSION 4 FILED
Friday, January 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 12, 2022TEAS EXTENSION RECEIVED
Saturday, June 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021SOU EXTENSION 3 GRANTED
Thursday, June 10, 2021SOU EXTENSION 3 FILED
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Saturday, January 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021SOU EXTENSION 2 GRANTED
Thursday, January 21, 2021SOU EXTENSION 2 FILED
Thursday, January 21, 2021TEAS EXTENSION RECEIVED
Friday, July 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 15, 2020SOU EXTENSION 1 GRANTED
Wednesday, July 15, 2020SOU EXTENSION 1 FILED
Wednesday, July 15, 2020TEAS EXTENSION RECEIVED
Tuesday, January 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 30, 2019ASSIGNED TO LIE
Friday, October 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 14, 2019NON-FINAL ACTION E-MAILED
Saturday, September 14, 2019NON-FINAL ACTION WRITTEN
Saturday, September 14, 2019ASSIGNED TO EXAMINER
Friday, July 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 28, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

airvoya drug device dilation balloon coated delivery system consisting pharmaceuticals used